Key result
Higher vitamin D levels linked to ~1% lower augmentation index per 3 ng/mL in youth with T2DM.
Why the study?
Does low serum 25[OH]D level correlate with increased arterial stiffness in youth with type 2 diabetes?
Cross-Sectional (n=570)
No
Does low serum 25[OH]D level correlate with increased arterial stiffness in youth with type 2 diabetes?
p-value: p=<0.01
Low serum vitamin D levels are independently associated with worsened central arterial stiffness in youth with type 2 diabetes, highlighting a potential modifiable target for early cardiovascular risk.
OBJECTIVE: Adult studies demonstrate that low vitamin D (25[OH]D) is an independent risk factor for arterial stiffness. Similar studies have not been conducted in youth with type 2 diabetes mellitus (T2DM). The objective was to elicit the association between 25[OH]D and arterial stiffness in obese youth with and without T2DM. We hypothesized that 25[OH]D would be inversely correlated with arterial stiffness indices, including pulse wave velocity (PWV), augmentation index (AIx), and brachial distensibility (BrachD). RESEARCH DESIGN AND METHODS: Cross-sectional analysis was conducted in Cincinnati, OH, from 2004 to 2010. 25[OH]D, PWV, AIx, and BrachD were measured in 190 youth with T2DM, 190 obese control subjects without T2DM, and 190 lean control subjects without T2DM. Multivariate analyses were conducted to elicit the independent association between 25[OH]D and arterial stiffness indices by group. RESULTS: The mean age was 17.9 ± 3.4 years, 55% were African American, and 34% were male. The mean 25[OH]D levels were 21.27, 14.29, and 14.13 ng/mL in lean individuals, obese individuals, and obese individuals with T2DM, respectively (P < 0.01). PWV, AIx, and BrachD worsened from lean to obese to T2DM (P < 0.01). General linear models found that 25[OH]D level was independently associated with PWV in lean individuals and with AIx in the group with T2DM such that a 3 ng/mL increase in 25[OH]D was associated with an AIx decrease of 1% (baseline AIx = 5.7 ± 12.0%). CONCLUSIONS: 25[OH]D is inversely associated with some measures of arterial stiffness in lean adolescents and obese adolescents with T2DM but not in obese normoglycemic adolescents. Future studies are needed to determine if supplemental 25[OH]D is important for cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Jha et al. (2015) conducted a cross-sectional in Type 2 Diabetes Mellitus and Obesity (n=570). Serum 25[OH]D level vs. Higher serum 25[OH]D level (continuous variable) was evaluated on Association between 25[OH]D and arterial stiffness indices (PWV, AIx, and BrachD) (p=<0.01). Serum 25[OH]D level was independently associated with the augmentation index (AIx) in youth with T2DM, such that a 3 ng/mL increase in 25[OH]D was associated with a 1% decrease in AIx.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: